You have 9 free searches left this month | for more free features.

Renoprotection

Showing 1 - 25 of 43

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Acute Kidney Injury, Cardiac Surgery, Sodium-Glucose Transporter 2 Inhibitor Trial in Netherlands (Dapagliflozin 10 MG Oral

Not yet recruiting
  • Acute Kidney Injury
  • +2 more
  • Dapagliflozin 10 MG Oral Tablet [Farxiga]
  • Placebo
  • Amsterdam, Netherlands
  • +5 more
Oct 18, 2022

Diabetic Nephropathy Trial in Phoenix (Losartan, Placebo)

Completed
  • Diabetic Nephropathy
  • Phoenix, Arizona
    NIDDK, Phoenix
Mar 2, 2021

Type 2 Diabetes, Diabetic Kidney Disease, Diabetic Nephropathy Trial in Amsterdam (Ertugliflozin 15 mg)

Recruiting
  • Type 2 Diabetes Mellitus
  • +6 more
  • Ertugliflozin 15 mg
  • Amsterdam, Netherlands
    VU University Medical Center
Mar 30, 2021

Type 2 Diabetes, Nephropathy Trial (MK0954, losartan / Duration of Treatment: mean 3.4 years, Placebo / Duration of Treatment:

Completed
  • Type 2 Diabetes
  • Nephropathy
  • MK0954, losartan / Duration of Treatment: mean 3.4 years
  • Placebo / Duration of Treatment: mean 3.4 years
  • (no location specified)
Feb 7, 2022

Myocardial Infarction Trial in Shibin Al Kawm (Dapagliflozin 10mg Tab, Placebo)

Recruiting
  • Myocardial Infarction
  • Dapagliflozin 10mg Tab
  • Placebo
  • Shibīn Al Kawm, Menofia, Egypt
    Mohammad Soliman
Aug 18, 2023

Chronic Kidney Diseases Trial in Belgium (Metformin Hydrochloride, Placebo Oral Tablet)

Recruiting
  • Chronic Kidney Diseases
  • Metformin Hydrochloride
  • Placebo Oral Tablet
  • Roeselare, West-Vlaanderen, Belgium
  • +18 more
Jan 19, 2021

Acute Kidney Injury Trial in Karachi (Dexmedetomidine, Normal Saline)

Completed
  • Acute Kidney Injury
  • Karachi, Sindh, Pakistan
    NICVD Karachi
May 11, 2022

Severe Malaria, Malaria,Falciparum, Acute Kidney Injury Trial in Kinshasa (Paracetamol, Mechanical antipyresis)

Recruiting
  • Severe Malaria
  • +3 more
  • Kinshasa, Congo, Congo, The Democratic Republic of the
    The Kinshasa Medical Oxford Research Unit (KIMORU)
Feb 17, 2022

Type2 Diabetes Trial in Amsterdam (EMPA/LINA 10/5 mg QD (n=22), LINA/EMPA 5/10 mg QD (N=22), Gliclazide 30 mg QD/BID (N=22))

Active, not recruiting
  • Type2 Diabetes
  • EMPA/LINA 10/5 mg QD (n=22)
  • +2 more
  • Amsterdam, Noord-Holland, Netherlands
    VU University Medical Center
Jan 13, 2022

Type 2 Diabetes, Diabetic Kidney Disease Trial in Changsha (Jinshuibao Capsule)

Active, not recruiting
  • Type 2 Diabetes Mellitus
  • Diabetic Kidney Disease
  • Jinshuibao Capsule
  • Changsha, Hunan, China
    The Second Xiangya Hospital of Central South University
Dec 7, 2020

Diabetic Nephropathies Trial in Cairo (SGLT2 inhibitor, ACE inhibitor)

Unknown status
  • Diabetic Nephropathies
  • SGLT2 inhibitor
  • ACE inhibitor
  • Cairo, Egypt
    Ain Shams University Hospitals
Apr 18, 2020

Diabetes Type 2 Trial in Doha (Metformin, Gliclazide, Sitagliptin)

Active, not recruiting
  • Diabetes Mellitus Type 2
  • Doha, Qatar
    Hamad Medical Corporation
Apr 27, 2022

COVID-19 Trial in Kermanshah (Deferoxamine)

Unknown status
  • COVID-19
  • Kermanshah, Iran, Islamic Republic of
    Regenerative Medicine Research Center, Kermanshah University of
Apr 30, 2020

Depressive Disorder, Major Trial (Dexmedetomidine Injection [Precedex], Normal saline)

Not yet recruiting
  • Depressive Disorder, Major
  • Dexmedetomidine Injection [Precedex]
  • Normal saline
  • (no location specified)
Dec 9, 2020

s of Kibow Biotics® in Chronic Kidney Failure

Completed
  • Chronic Kidney Failure
    • Brooklyn, New York
    • +1 more
    Aug 16, 2019

    Diabetes Trial in Italy (Benazepril, Valsartan, Benazepril/Valsartan)

    Completed
    • Diabetes
    • Ponte San Pietro, Bergamo, Italy
    • +8 more
    Sep 3, 2019

    Kibow Biotics in Chronic Kidney Failure Patients on Dialysis

    Completed
    • Chronic Kidney Disease
    • Kibow Biotics
    • Brooklyn, New York
      Parkside Dialysis Clinic at Downstate Medical Center
    Aug 16, 2019

    Observational Study of Kibow Biotics in Dialysis Patients

    Completed
    • Chronic Kidney Failure
    • Kibow Biotics
    • Philadelphia, Pennsylvania
      Thomas Jefferson University
    Aug 16, 2019

    Diabetes, Type 2, Diabetic Nephropathies Trial in Amsterdam (Dapagliflozin 10mg QD, Gliclazide 30mg QD)

    Completed
    • Diabetes Mellitus, Type 2
    • Diabetic Nephropathies
    • Dapagliflozin 10mg QD
    • Gliclazide 30mg QD
    • Amsterdam, Noord-Holland, Netherlands
      VU University Medical Center
    Jul 6, 2020

    Type 2 Diabetes, Diabetic Nephropathy Trial in Xiamen (SGLT2 Inhibition)

    Unknown status
    • Type 2 Diabetes
    • Diabetic Nephropathy
    • SGLT2 Inhibition
    • Xiamen, Fujian, China
      Zhongshan Hospital Xiamen University
    Oct 16, 2019

    Vascular Calcification in Diabetic Nephropathy in Diabetic

    Unknown status
    • Diabetic Nephropathies
    • Vascular Calcification
    • Osteopontin (OPN)
    • Asyūţ, Egypt
      Assiut University
    Jan 26, 2019

    Contrast-induced Nephropathy Trial in Cali (Ischemic preconditioning, Endovenous normal saline)

    Withdrawn
    • Contrast-induced Nephropathy
    • Ischemic preconditioning
    • Endovenous normal saline
    • Cali, Valle Del Cauca, Colombia
      Grupo Nefrología Fundación Valle del Lili
    Oct 9, 2018

    Chronic Renal Failure Trial in Taipei (ARB, Pentoxifylline, Placebo (for Pentoxifylline))

    Unknown status
    • Chronic Renal Failure
    • Taipei, Taiwan
      National Taiwan University Hospital
    Oct 13, 2016

    Autosomal Dominant Polycystic Kidney Disease Trial in Italy (Octreotide-LAR, Saline solution.)

    Completed
    • Autosomal Dominant Polycystic Kidney Disease
    • Agrigento, AG, Italy
    • +5 more
    Jan 9, 2018

    Pentoxifylline, Acute Kidney Injury Trial (Pentoxifylline 400Mg Tablet)

    Unknown status
    • Pentoxifylline
    • Acute Kidney Injury
    • Pentoxifylline 400Mg Tablet
    • (no location specified)
    Apr 24, 2017